THE IMPACT OF IMMUNOHISTOCHEMICAL MARKER INDICATORS ON TREATMENT OUTCOMES IN ENDOMETRIAL ATYPICAL HYPERPLASIA. World Bulletin of Public Health, v. 52, p. 46–50, 28 Dec.2025.